Skip to main content
. 2022 Jun 18;47(13):2300–2308. doi: 10.1038/s41386-022-01359-5

Fig. 2. Day-of-injury blood biomarker concentrations among those without and with probable PTSD at 6-month outcome.

Fig. 2

a (top): Day-of-injury plasma GFAP concentrations among those without (“no”) and with (“yes”) probable PTSD at 6-month outcome. b (bottom): Day-of-injury serum hsCRP concentrations among those without (“no”) and with (“yes”) probable PTSD at 6-month outcome post-injury.

HHS Vulnerability Disclosure